Marshall Wace, LLP Abbott Laboratories Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

A detailed history of Marshall Wace, LLP transactions in Abbott Laboratories stock. As of the latest transaction made, Marshall Wace, LLP holds 123,227 shares of ABT stock, worth $14.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

123,227

Previous 216,337 43.04%

Holding current value

$14.1 Million

Previous $22.5 Million 37.5%

% of portfolio

0.02%

Previous 0.03%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $9.32 Million - $11 Million	-93,110 Reduced 43.04%	123,227 $14 Million
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $21.7 Million - $24.2 Million	215,537 Added 26942.13%	216,337 $22.5 Million
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $15.2 Million - $16.8 Million	-138,743 Reduced 99.43%	800 $90,000
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $9.51 Million - $11.6 Million	105,495 Added 309.84%	139,543 $15.4 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $20.5 Million - $24.6 Million	-214,769 Reduced 86.32%	34,048 $3.3 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $24.7 Million - $27.5 Million	244,912 Added 6271.75%	248,817 $27.1 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $378,238 - $445,209	3,905 New	3,905 $395,000
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $55 Million - $66.4 Million	-538,568 Reduced 94.44%	31,698 $3.44 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $77.6 Million - $94.6 Million	-680,519 Reduced 54.41%	570,266 $67.5 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $116 Million - $142 Million	1,005,234 Added 409.38%	1,250,785 $176 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $3.39 Million - $3.76 Million	-29,097 Reduced 10.59%	245,551 $29 Million
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $11.9 Million - $14 Million	112,673 Added 69.56%	274,648 $31.8 Million
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $17.6 Million - $20.8 Million	161,975 New	161,975 $19.4 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $4.69 Million - $5.11 Million	-44,625 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$91.64 - $111.29 $4.45 Million - $5.4 Million	-48,541 Reduced 52.1%	44,625 $4.86 Million
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $7.13 Million - $9.13 Million	93,166 New	93,166 $8.52 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $26.9 Million - $39.4 Million	-428,876 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $33.4 Million - $37.2 Million	425,258 Added 11753.95%	428,876 $37.3 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $2.28 Million - $2.47 Million	-27,816 Reduced 88.49%	3,618 $303,000
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $2.29 Million - $2.67 Million	31,434 New	31,434 $2.64 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $230,165 - $277,667	-3,785 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $2.31 Million - $2.54 Million	-40,053 Reduced 91.37%	3,785 $231,000
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $17.7 Million - $20 Million	-313,864 Reduced 87.74%	43,838 $2.63 Million
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $10.8 Million - $11.6 Million	201,189 Added 128.54%	357,702 $20.4 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $7.52 Million - $8.4 Million	156,513	156,513 $8.3 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Abbott Laboratories Transaction History